Australia markets open in 9 hours 29 minutes

Cartesian Therapeutics, Inc. (RNAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.97-0.65 (-3.69%)
At close: 04:00PM EDT
16.80 -0.17 (-1.00%)
After hours: 07:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 362.47M
Enterprise value 269.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.44
Price/book (mrq)31.26
Enterprise value/revenue 10.40
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-48.10%
S&P500 52-week change 326.25%
52-week high 342.60
52-week low 311.66
50-day moving average 325.83
200-day moving average 325.22

Share statistics

Avg vol (3-month) 3141.59k
Avg vol (10-day) 3335.48k
Shares outstanding 521.36M
Implied shares outstanding 617.8M
Float 83.6M
% held by insiders 160.66%
% held by institutions 111.12%
Shares short (14 June 2024) 4811.44k
Short ratio (14 June 2024) 48.6
Short % of float (14 June 2024) 440.21%
Short % of shares outstanding (14 June 2024) 44.56%
Shares short (prior month 15 May 2024) 4948.36k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 305 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-223.43%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)25.91M
Revenue per share (ttm)4.94
Quarterly revenue growth (yoy)-1.70%
Gross profit (ttm)N/A
EBITDA -68.26M
Net income avi to common (ttm)-292.42M
Diluted EPS (ttm)-56.06
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)103.42M
Total cash per share (mrq)5.81
Total debt (mrq)10.46M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.03
Book value per share (mrq)-21.17

Cash flow statement

Operating cash flow (ttm)-58.31M
Levered free cash flow (ttm)N/A